Topic Review
Chios Mastic Gum (Pistacia lentiscus) for Human Health
Despite the remarkable development of the medical industry in the current era, herbal products with therapeutic potentials arise as attractive alternative treatments. Consequently, Chios mastiha, a natural, aromatic resin obtained from the trunk and brunches of the mastic tree, has recently gained increasing scientific interest due to its multiple beneficial actions. Chios mastiha is being exclusively produced on the southern part of Chios, a Greek island situated in the northern Aegean Sea, and its therapeutic properties have been known since Greek antiquity. There is now substantial evidence to suggest that mastiha demonstrates a plethora of favorable effects, mainly attributed to the anti-inflammatory and anti-oxidative properties of its components. The main use of mastiha nowadays, however, is for the production of natural chewing gum, although an approval by the European Medicines Agency for mild dyspeptic disorders and for inflammations of the skin has been given. 
  • 771
  • 18 Feb 2022
Topic Review
CD163
In ischemic stroke patients, a higher monocyte count is associated with disease severity and worse prognosis. The complex correlation between subset phenotypes and functions underscores the importance of clarifying the role of monocyte subpopulations. We examined the subtype-specific distribution of the CD163+ and CD80+ circulating monocytes and evaluated their association with the inflammatory status in 26 ischemic stroke patients and 16 healthy controls.
  • 771
  • 15 Jul 2021
Topic Review
Pathophysiological Perspective of Osteoarthritis
Osteoarthritis (OA) is the most well-known disease among the geriatric and the main cause of significant disability in daily living. It has a multifactorial aetiology and characterized by pathological changes of knee joint structure including cartilage erosion, synovial inflammation and subchondral sclerosis with osteophyte formation. To date, no efficient treatment is capable of altering the pathological progression of OA. This topic described significant mediators such as cytokines, proteolytic enzymes, and nitric oxide, that trigger the loss of the normal homeostasis and structural changes in the articular cartilage during the progression of OA.
  • 771
  • 02 Dec 2020
Topic Review
Molecular Therapeutics for Corneal Scar Treatment
The process of corneal wound healing is complex and induces scar formation. Corneal scarring is a leading cause of blindness worldwide. The fibrotic healing of a major ocular wound disrupts the highly organized fibrillar collagen arrangement of the corneal stroma, rendering it opaque. The process of regaining this organized extracellular matrix (ECM) arrangement of the stromal layer to restore corneal transparency is complicated. The surface retention capacity of ocular drugs is poor, and there is a large gap between suitable corneal donors and clinical requirements. 
  • 770
  • 04 Nov 2022
Topic Review
Nanotechnology-facilitated Bacterial Therapy
In recent years, advancing nanotechnology has extended bacterial therapies to a higher level through tailoring bacteria on a nanoscale, such as bacteria-derived nanovesicles and bacterial membrane-coated nanoparticles, or endowing bacteria with abilities to serve as drug carriers, photosensitizers, and sonosensitizers.
  • 770
  • 09 Jul 2021
Topic Review
Interleukins
Interleukins (ILs) regulate differentiation and function of bone cells, with several ILs being reported to act pro-osteoclastogenic. 
  • 770
  • 24 May 2021
Topic Review
Small Leucine-Rich Proteoglycans in Retina
Small Leucine-Rich Proteoglycans (SLRPs) are key extracellular matrix proteins that play a role in many fundamental biological processes involved in the maintenance of retinal homeostasis. 
  • 770
  • 26 Jul 2021
Topic Review
Papillary Thyroid Carcinoma
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer in both adult and pediatric populations, occurring more commonly in women at ages 50-59. PTC is characterized by the presence of cells arranged into papillae, presenting clear or ground-glass nuclei. It is further subdivided based on histological variants, such as the classic (CVPTC), follicular (FVPTC), solid (SVPTC), and diffuse sclerosing (DSVPTC) variants.
  • 770
  • 18 Nov 2020
Topic Review
Hearing Impairment
Hearing impairment (HI), also referred to as hearing loss, is the partial or total loss of hearing. GJB2 is the most common gene associated with HI and it belongs to a family of genes that encodes connexin proteins. Over seven connexins (GJB3, GJB4, GJC3, GJC1, GJB2, GJB6, and GJA1) have been globally studied for their association with HI, however, the majority did not have a clearly established association with the condition. Although there were studies that reported variants in  GJB3, GJB4, GJC3, and GJC1 in hearing-impaired patients, there is a need for more studies to clearly describe their role in the development of HI. GJB2, GJB6, and GJA1 on the other hand have been identified as HI genes that should be considered in routine clinical investigations. Recent data has shown that the coding region variants of GJB6 (except the large genomic deletions) do not contribute to the development of HI.
  • 770
  • 12 Nov 2020
Topic Review
Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
The intestinal mucosal barrier, also referred to as intestinal barrier, is widely recognized as a critical player in gut homeostasis maintenance as it ensures the complex crosstalk between gut microbes (both commensals and pathogens) and the host immune system. Highly specialized epithelial cells constantly cope with several protective and harmful agents to maintain the multiple physiological functions of the barrier as well as its integrity. However, both genetic defects and environmental factors can break such equilibrium, thus promoting gut dysbiosis, dysregulated immune-inflammatory responses, and even the development of chronic pathological conditions.
  • 770
  • 17 Feb 2022
  • Page
  • of
  • 1352
Video Production Service